Acquistion

CRO Parexel to be acquired by Goldman Sachs in $8.5b deal

08-Jul-2021 By Jenni Spinner

The global contract research organization has announced it will be purchased by Goldman Sachs Asset Management and EQT Private Equity.

Acquisition adds European design to ACG’s manufacturing services

06-Aug-2019 By Maggie Lynch

ACG Engineering acquires Xertecs to add European design to its existing Indian engineering and manufacturing capabilities as it globalizes.

Acquisition of two treatments ‘rounds out’ Upsher-Smiths migraine portfolio

01-Aug-2019 By Maggie Lynch

The acquisition of two migraine therapies from Dr Reddy’s has been completed by Upsher-Smith, adding different drug delivery treatment options to its migraine product portfolio.

PE firm continues investments in health care industry by taking a stake in Jaggaer

15-Jul-2019 By Maggie Lynch

The strategic sourcing software company Jaggaer has received an investment from international PE firm Cinven.

Acquisition of Novartis’ Swiss site gives Lonza its first sterile drug product facility

01-Jul-2019 By Maggie Lynch

Lonza adds its first sterile drug product fill-finish facility to its network after acquiring Novartis’ Swiss plant, building on its parenteral drug product development and testing capabilities for clinical trial supply.

Cognizant acquires Zenith to become single source provider

18-Jun-2019 By Maggie Lynch

Zenith-Cognizant Technologies emerges from an acquisition aimed to streamline solutions as more complex “smart factories” become a greater focus in the biopharmaceutical industry.

PE firm Ampersand acquires German CDMO Vibalogics

03-Jun-2019 By Maggie Lynch

The private equity firm Ampersand Capital has acquired Vibalogics with plans to increase development and manufacturing capabilities for complex viral products.

WCG targets pain management, opioid alternatives in Analgesic Solutions deal

08-Apr-2019 By Maggie Lynch

WCG acquires Analgesic Solutions for advisement on protocol design and the development of clinical trials in which pain is an indicator of an underlying condition.

Digoxin API supply secured through acquisition

26-Mar-2019 By Maggie Lynch

C2 Pharma acquires digoxin API product portfolio from Noblius to secure supply of the ingredient, after disruption of the supply of the API for a number of years.

IRB consolidation: Advarra acquires Quorum Review and Kinetiq

05-Mar-2019 By Melissa Fassbender

The institutional review board industry sees further consolidation as Advarra acquires Quorum and its research and technology consulting division, Kinetiq.

Ipsen adds to rare disease portfolio with $1.3bn Clementia deal

26-Feb-2019 By Maggie Lynch

Ipsen acquires Clementia and takes on late-stage clinical asset for the treatment of rare bone disorders, in its largest transaction to date.

Caprion expands assay development services after acquisition

15-Jan-2019 By Maggie Lynch

Caprion Biosciences will provide mass cytometry services to expand its offerings as a specialty CRO after its acquisition of Primity Bio.

MilliporeSigma and genOway enter CRISPR collaboration

19-Dec-2018 By Maggie Lynch

genOway has acquired exclusive rights to MilliporeSigma's genome-editing patents to produce and sell new rodent models.

GSK rebuilds oncology pipeline with $5.1bn acquisition

04-Dec-2018 By Maggie Lynch

GSK entered an agreement with Tesaro to gain ‘under-appreciated’ PARP inhibitor assets and a Boston base.

PE firm brings CROs together, putting assay development and testing under one roof

20-Nov-2018 By Maggie Lynch

The PE firm Ampersand Capital Partners has acquired Pacific Biomarkers and is merging the CRO with Neomed-Labs to streamline clinical immunology development.